ABDUL RASHEED MOHAMMED,ANIL KARBHARI SHINDE,RAMAKRISHNA NIROGI,SHANKAR REDDY GAGGINAPALLY,VENKATESWARLU JASTI
申请号：
BR112016013974
公开号：
BR112016013974A8
申请日:
2014.02.24
申请国别(地区):
BR
年份:
2018
代理人:
摘要：
The present invention relates to novel indazole compounds having formula (I), including their stereoisomers and pharmaceutically acceptable salts thereof. The present invention also relates to methods of producing said compounds and pharmaceutical compositions comprising said compounds. The compounds of the present invention are useful in treating various disorders that are related to 5-hydroxytryptamine 4 (5-ht4) receptor agonists.a presente invenção se refere a novos compostos indazola tendo a fórmula (i), que incluem os seus estereoisômeros e os seus sais farmaceuticamente aceitáveis. a presente invenção também se refere a métodos de produzir os referidos compostos e composições farmacêuticas que compreendem os referidos compostos. os compostos da presente invenção são úteis no tratamento de várias desordens que são relacionadas aos agonistas receptores de 5- hidroxitriptamina 4 (5-ht4).
